Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 6, 2023
Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality
C Terrones-Campos, B Ledergerber, N Forbes, et al.
Clinical and Experimental Immunology
|
August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis
M Hersberger, S Bonhoeffer, S K Rampini, et al.
AIDS (London, England)
|
October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study
A C Friedl, B Ledergerber, M Flepp, et al.
JAMA
|
November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
A N Phillips, S Staszewski, R Weber, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 3, 2004
Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001
I Yust, Z Fox, M Burke, et al.
HIV Medicine
|
June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
R Weber, M Huber, M Rickenbach, et al.
HIV Medicine
|
May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
J Schäfer, J Young, E Bernasconi, et al.
Infection
|
September 19, 2012
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study
Y Achermann, K Eigenmann, B Ledergerber, et al.
HIV Medicine
|
June 5, 2014
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients
D L Braun, A Rauch, N Durisch, et al.
HIV Medicine
|
September 4, 2010
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study
J Reekie, P Reiss, B Ledergerber, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 6, 2023
Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality
C Terrones-Campos, B Ledergerber, N Forbes, et al.
Clinical and Experimental Immunology
|
August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis
M Hersberger, S Bonhoeffer, S K Rampini, et al.
AIDS (London, England)
|
October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study
A C Friedl, B Ledergerber, M Flepp, et al.
JAMA
|
November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
A N Phillips, S Staszewski, R Weber, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 3, 2004
Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001
I Yust, Z Fox, M Burke, et al.
HIV Medicine
|
June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
R Weber, M Huber, M Rickenbach, et al.
HIV Medicine
|
May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
J Schäfer, J Young, E Bernasconi, et al.
Infection
|
September 19, 2012
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study
Y Achermann, K Eigenmann, B Ledergerber, et al.
HIV Medicine
|
June 5, 2014
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients
D L Braun, A Rauch, N Durisch, et al.
HIV Medicine
|
September 4, 2010
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study
J Reekie, P Reiss, B Ledergerber, et al.
Page
of 12